Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Other Non-Current Assets: 2014-2025

Historic Other Non-Current Assets for Zevra Therapeutics (ZVRA) over the last 10 years, with Sep 2025 value amounting to $153,000.

  • Zevra Therapeutics' Other Non-Current Assets fell 70.12% to $153,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $153,000, marking a year-over-year decrease of 70.12%. This contributed to the annual value of $384,000 for FY2024, which is 308.51% up from last year.
  • Latest data reveals that Zevra Therapeutics reported Other Non-Current Assets of $153,000 as of Q3 2025, which was down 30.45% from $220,000 recorded in Q2 2025.
  • In the past 5 years, Zevra Therapeutics' Other Non-Current Assets registered a high of $1.8 million during Q1 2024, and its lowest value of $53,000 during Q4 2022.
  • For the 3-year period, Zevra Therapeutics' Other Non-Current Assets averaged around $415,545, with its median value being $220,000 (2025).
  • Per our database at Business Quant, Zevra Therapeutics' Other Non-Current Assets tumbled by 87.95% in 2023 and then soared by 3,269.81% in 2024.
  • Over the past 5 years, Zevra Therapeutics' Other Non-Current Assets (Quarterly) stood at $438,000 in 2021, then slumped by 87.90% to $53,000 in 2022, then skyrocketed by 77.36% to $94,000 in 2023, then spiked by 308.51% to $384,000 in 2024, then slumped by 70.12% to $153,000 in 2025.
  • Its Other Non-Current Assets was $153,000 in Q3 2025, compared to $220,000 in Q2 2025 and $293,000 in Q1 2025.